Nasal flu vaccine study in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests how healthy adults respond to the nasal flu vaccine. You may be able to help researchers learn more about how the body reacts to this vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have not smoked or vaped in the past 6 months
- You do not have any long-term lung disease or other serious health conditions
- You do not currently have a cold or respiratory infection, and haven't had one in the past month
- You have not received this season's flu vaccine yet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study tests how the immune system in your nose and airways responds to the FluMist nasal spray flu vaccine. It may help doctors understand why some people get better protection from the flu.
This study tests if a new nasal spray flu vaccine is safe and effective for preventing flu in healthy adults aged 18 to 59. If you've had the flu recently or have certain health conditions, this trial may not be for you.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
Hear when a new Mucosal Immune Response to Influenza Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.